- Home
- Applications
- europe
- clinic celiacshield trial
Refine by
Clinic Celiacshield Trial Product Applications In Europe
24 applications found
N-[(3-Trifluoromethyl)phenyl)propyl] Cinacalcet is an impurity of Cinacalcet Hydrochloride. Cinacalcet is used in clinical trial in secondary hyperparathyroidism.https://www.bocsci.com/cinacalcet-impurity-d-cas-1271930-15-4-item-468972.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
This trial uses our unmodified GDT cells derived from healthy donors, in a dose escalation study to establish safety of the allogeneic platform. This trial is open. ...
ByTC BioPharm based in Holytown, UNITED KINGDOM
With 3BP’s theragnostic approach, you can see where your drug is going and monitor the efficacy of the treatment. This allows the identification of likely responders leading to faster and cost-efficient clinical trials and increased chances of successful treatment. It also allows personalized dosing based on individual imaging data, thus achieving maximal therapeutic effect with minimal unwanted side effects. ...
By3B Pharmaceuticals GmbH based in Berlin, GERMANY
This trial investigated the safety profile of large numbers of GDT cells derived from patients and was open to certain patients with skin, kidney or lung cancers. This trial is now closed. ...
ByTC BioPharm based in Holytown, UNITED KINGDOM
Antigens can be carried by liposomes, either lipids, proteins, DNA or RNA. They can also be combined with bacteria or virus components to form archaeosomes or virosomes, respectively. These vaccines have been proved to be effective in inducing immune responses and providing a sustained exposure to the antigen. More than 30 clinical trials are currently using liposomes for vaccine delivery including HIV and several types of ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Challenge: Aging is most visible in the face, yet it is the most difficult area of skin assessment. We enable: Personalized skin assessment and individual monitoring of aging in the ...
ByCitus AG based in Dübendorf, SWITZERLAND
The development of highly cytotoxic drugs is needed for the success of the treatment in tumor cells. Paradoxically, the high toxicity limits its efficacy and application in vivo, causing damage to non-target organs and severe secondary effects. The use of directed liposomes has allowed the advance of many cancer drugs to preclinical and clinical trials, reducing side effects, and increasing their therapeutic index at the same time. More than 15 cancer liposomed drugs are currently clinically ...
ByNanovex Biotechnologies based in Llanera, SPAIN
PLGA nanospheres have already been successfully used in vitro and in clinical trials. Results show that drugs encapsulated in PLGA nanoparticles have superior accumulation in the tumor environment, reduced tumor size and enhanced inhibition of cell proliferation. This is thanks to increased cell penetration and reduced toxicity of encapsulated compounds. Because of the higher accumulation in tumoral areas PLGA nanoparticles are also useful for cancer diagnosis and imaging which has a key role in clinical oncology ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Nuubo considers that cutting edge technology can only be considered as such if it also works in real life, with real patients living a normal life. That is why Nuubo is strongly focused on clinical research. Apart from the completed and published studies, Nuubo currently has approximately 3500 patients enrolled in ongoing clinical trials, validating the Nuubo technology for real clinical use. Nuubo is conducting studies in the following ...
ByNuubo based in Edificio Spaces, SPAIN
By using our platform, we provide great opportunities for integrating metagenomic analysis into translational parts of pharmaceutical development. Our experience in metagenomic evaluation of large patient cohorts provides know-how and understanding regarding microbiome related conditions and can be applied for target evaluation, and for biomarker identification and development of subsequent patient stratification tools. The MetaboGen network contains clinicians specialized in various diseases, providing access to ...
ByMetabogen AB based in Stockholm, SWEDEN
Combining cutting edge-innovation, a long tradition as the “world´s pharmacy” and continuously growing demand for healthcare products, Germany is the ideal location for pharmaceutical R&D, production, and sales of medicines.Driven by trends such as demographic change, a rise in chronic diseases and an increasing emphasis on prevention and self-medication, Europe’s biggest pharmaceutical market is growing faster than the German economy. Germany belongs to the world’s leading ...
ByGermany Trade & Invest based in Berlin, GERMANY
Point-of-Care Testing at Doctor’s Office, in Hospitals & Clinics, Mobile Testing at Patient Side, Clinical Trials, Govermental Healthcare Programs, NGO based Healthcare Screening Programs (WHO, Unicef) ...
ByChembio Diagnostics GmbH based in Berlin, GERMANY
We are collaborating with leading hospitals, integrated health systems, medical centers and biobanks around the world to conduct studies in order to further develop and validate UDX's blood test for early cancer ...
ByUniversal Diagnostics SL based in Seville, SPAIN
With Qynapse we all benefit from earlier and more accurate monitoring of patients. Patients, practitioners, researchers and you – the payer, all benefit from earlier, more accurate central nervous system disease diagnosis and monitoring of patients throughout the care continuum. Qynapse has the potential to help lower costs, drive up quality outcomes and improve patient satisfaction. Are you ready to transform neuroscience with us? ...
ByQynapse based in Paris, FRANCE
The trespassing of the blood brain barrier is a challenge for the treatment of central nervous diseases such as Alzheimer, Parkinson, stroke, or cancer (glioma). The endothelium shows tight junctions and specialized transporters which limits the bioavailability of drugs in the central nervous ...
ByNanovex Biotechnologies based in Llanera, SPAIN
With Quasi Vivo, Kirkstall’s flow system, you can quickly and easily set up and run in vitro assays to detect hepatotoxicity of novel compounds. ...
ByKirkstall Ltd. based in York, UNITED KINGDOM
See clearly and quickly with Qynapse’s AI-powered neuroimaging software platform. Our quest is to enhance your clinical trial design and increase the likelihood of trial success by leveraging our precise and objective AI-powered neuroimaging software platform. ...
ByQynapse based in Paris, FRANCE
Unlike conventional vaccination strategies, cancer vaccines are designed to mount responses against tumor-specific antigens, arising from somatic mutations specific to the cancer genome. They promise a highly tailored approach by targeting patient-specific ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
ROTA xfillR aseptic filling system is the perfect fit for processing the smallest batches in research and development as well as in the production of batches for clinical trials in the pharmaceutical and biotech industry. Filling different containers with just one extremely compact machine means not only time and cost savings, but also an investment in flexibility and thus lasting ...
ByRota Verpackungstechnik GmbH & Co.KG based in Wehr, GERMANY
How can Raman microscopy help the battle to quit smoking? A transdermal patch is a method of drug delivery through the skin into the bloodstream. The patch contains a drug which absorbs into your skin when attached to you and it releases a consistent ...
ByEdinburgh Instruments - TECHCOMP Group based in , UNITED KINGDOM